InDex Pharmaceuticals Holding AB Financial Overview
InDex Pharmaceuticals Holding AB's market cap is currently €3.24B. The company's EPS TTM is kr2.222; its P/E ratio is 0.29; InDex Pharmaceuticals Holding AB is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
InDex Pharmaceuticals Holding AB Earnings and Revenue History
